ZA200200299B - Thiophene A2A receptor agonists. - Google Patents

Thiophene A2A receptor agonists.

Info

Publication number
ZA200200299B
ZA200200299B ZA200200299A ZA200200299A ZA200200299B ZA 200200299 B ZA200200299 B ZA 200200299B ZA 200200299 A ZA200200299 A ZA 200200299A ZA 200200299 A ZA200200299 A ZA 200200299A ZA 200200299 B ZA200200299 B ZA 200200299B
Authority
ZA
South Africa
Prior art keywords
thiophene
receptor agonists
disclosed
purposes
alkylthienyl
Prior art date
Application number
ZA200200299A
Other languages
English (en)
Inventor
Jeffrey A Zablocki
Elfatih O Elzein
Venkata P Palle
Original Assignee
Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutics Inc filed Critical Therapeutics Inc
Publication of ZA200200299B publication Critical patent/ZA200200299B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200200299A 1999-06-22 2002-01-14 Thiophene A2A receptor agonists. ZA200200299B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14047899P 1999-06-22 1999-06-22

Publications (1)

Publication Number Publication Date
ZA200200299B true ZA200200299B (en) 2003-08-27

Family

ID=22491411

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200299A ZA200200299B (en) 1999-06-22 2002-01-14 Thiophene A2A receptor agonists.

Country Status (19)

Country Link
US (1) US6440948B1 (zh)
EP (1) EP1194441B1 (zh)
JP (1) JP2003502434A (zh)
KR (1) KR100463694B1 (zh)
CN (1) CN1166677C (zh)
AT (1) ATE252595T1 (zh)
AU (1) AU768530B2 (zh)
BR (1) BR0011853A (zh)
CA (1) CA2373410C (zh)
DE (1) DE60006116T2 (zh)
ES (1) ES2206259T3 (zh)
HK (1) HK1048821B (zh)
IL (2) IL147194A0 (zh)
MX (1) MXPA01013323A (zh)
NO (1) NO20016242L (zh)
NZ (1) NZ516336A (zh)
TR (1) TR200200617T2 (zh)
WO (1) WO2000078776A2 (zh)
ZA (1) ZA200200299B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023457A1 (en) * 1998-10-16 2000-04-27 Pfizer Limited Adenine derivatives
HUP0402591A2 (hu) 2002-02-15 2005-09-28 Cv Therapeutics, Inc. Polimer bevonat orvosi eszközök számára
TWI346109B (en) 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
KR101267202B1 (ko) 2004-05-26 2013-05-24 이노텍 파마슈티컬스 코포레이션 아데노신 ａ1 수용체 아고니스트로서의 퓨린 유도체 및 이것의 사용 방법
EP1802316B1 (en) * 2004-09-20 2011-11-02 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
WO2007064795A2 (en) * 2005-11-30 2007-06-07 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
BR112012017106A2 (pt) 2010-01-11 2018-05-29 Inotek Pharmaceuticals Corp combinação, kit e método de redução de pressão intraocular.
SG184221A1 (en) 2010-03-26 2012-10-30 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
MX2014009086A (es) 2012-01-26 2015-06-05 Inotek Pharmaceuticals Corp Polimorfos anhidros de nitrato de [ (2r,3s,4r,5r) -5- (6- (ciclopentilamino) -9h-purin-9-il) -3,4-dihidroxitetra-hidrofuran- 2-il) ] metilo y procesos para su preparación.
NZ630759A (en) 2013-03-15 2017-07-28 Inotek Pharmaceuticals Corp Ophthalmic formulations comprising an a1 agonist
RU2742417C1 (ru) 2017-01-13 2021-02-05 Тобиси Фармасьютикал Ко., Лтд. Регулятор активации нейтрофилов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) * 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS4911896A (zh) * 1972-05-15 1974-02-01
JPS5518625B2 (zh) * 1973-07-26 1980-05-20
US5070877A (en) 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
CA2107667A1 (en) * 1991-04-06 1992-10-07 Anthony Howard Ingall Atp analogues

Also Published As

Publication number Publication date
KR100463694B1 (ko) 2004-12-29
DE60006116T2 (de) 2004-07-08
HK1048821B (zh) 2005-02-25
EP1194441B1 (en) 2003-10-22
US6440948B1 (en) 2002-08-27
NO20016242D0 (no) 2001-12-19
IL147194A (en) 2007-08-19
CA2373410C (en) 2006-08-29
KR20020028912A (ko) 2002-04-17
NO20016242L (no) 2002-02-21
ATE252595T1 (de) 2003-11-15
JP2003502434A (ja) 2003-01-21
CN1166677C (zh) 2004-09-15
HK1048821A1 (en) 2003-04-17
WO2000078776A3 (en) 2001-06-28
MXPA01013323A (es) 2003-10-15
ES2206259T3 (es) 2004-05-16
AU768530B2 (en) 2003-12-18
EP1194441A2 (en) 2002-04-10
CA2373410A1 (en) 2000-12-28
CN1364170A (zh) 2002-08-14
TR200200617T2 (tr) 2002-06-21
AU5625100A (en) 2001-01-09
BR0011853A (pt) 2002-04-30
NZ516336A (en) 2004-01-30
IL147194A0 (en) 2002-08-14
DE60006116D1 (de) 2003-11-27
WO2000078776A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
CA2377746A1 (en) N-pyrazole a2a receptor agonists
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
NZ522326A (en) Adenosine A2A receptor antagonists
IL147194A0 (en) Thiophene a2a receptor agonists
TNSN99191A1 (fr) Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2375385A1 (en) Propargyl phenyl ether a2a receptor agonists
DK0975595T3 (da) Kokainanaloger
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
TR200201001T2 (tr) Pürin türevleri
JO2503B1 (en) Benzathiazole derivatives
LU91599I2 (fr) Lasofoxifene, optionnellement sous forme d'un sel d'addition acide, d'un N-oxyde, d'unester ou d'un sel d'ammonium quaternaire, non toxiques et pharmacologiquement acceptables, y compris le sel tartrate (FABLYN - lasofoxifene)
MXPA03001344A (es) Derivados de piridina 2,4-substituidos.
IL137266A0 (en) Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
DE60003837D1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
DE50211929D1 (en) Pyrimidinderivate
DK0476066T3 (da) Antiviralt præparat indeholdende 3-azido-2,3-dideoxy-5-methylcytidin
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
PL335016A1 (en) Novel polymorph of 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl]-1-phtalazine acetic acid monohydrate, method of obtaining same, method of obtaining anhydrous 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl-1-phtalazine acetic acid, therapeutic methods, pharmaceutic agent, application of said polymorph in production of such pharmaceutic agent and method of obtaining the last mentioned one
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
CN100480255C (zh) A1腺苷受体的部分和完全激动剂
UA74421C2 (uk) Похідні індолону, які є антагоністами gal3 рецептора для лікування депресії і/або тривоги та композиції, придатні для такого лікування
CA2304821A1 (en) Osteoblast-specific mitogens and drugs containing such compounds
DE60008589D1 (de) Zusammensetzungen von adenosin a1 agonisten mit 5ht1 agonisten
EP0370821A3 (en) 1,4-dihydropyridine derivatives